Group 1 - The core point of the news is that southbound funds have significantly increased their holdings in Jinxin Reproductive Medicine (01951.HK), with a total net increase of 34.82 million shares over the past five trading days [1] - As of September 19, 2025, southbound funds hold 1.42 billion shares of Jinxin Reproductive Medicine, accounting for 51.47% of the company's total issued ordinary shares [1] - In the last 20 trading days, there have been 17 days of net increases in holdings by southbound funds, totaling 126 million shares [1] Group 2 - The trading data shows that on September 19, 2025, the total number of shares held was 1.42 billion, with a change of 11.25 million shares, representing a 0.80% increase [2] - The previous trading days also show consistent increases in holdings, with notable changes of 6.91 million shares (0.49%) on September 18, 2025, and 9.14 million shares (0.66%) on September 17, 2025 [2] - Jinxin Reproductive Medicine is primarily engaged in providing in vitro fertilization (IVF) services and operates mainly in China and the United States [2]
锦欣生殖（01951.HK）：9月19日南向资金增持1125.4万股